AspenBio Pharma changes its name to Venaxis

AspenBio Pharma changes its name to Venaxis

CASTLE ROCK - Venaxis Inc. (Nasdaq: APPY) - formerly AspenBio Pharma - has changed its corporate name after a recent meeting of its shareholders, the company announced. The company's... Read More

By: Steve Friday December 14, 2012 0 comments Tags: AspenBio Pharma, Castle Rock, Steve Lundy, Venaxis

AspenBio Pharma earns $3.7 million in stock sale to help fund clinical trial

AspenBio Pharma earns $3.7 million in stock sale to help fund clinical trial

CASTLE ROCK - AspenBio Pharma Inc. (Nasdaq: APPY) announced it closed on a public offering of 1,946,000 shares of its common stock at a price of $2.10 per share. After expenses, the company... Read More

By: Steve Wednesday November 21, 2012 0 comments Tags: AspenBio Pharma, Castle Rock

AspenBio Pharma seeks name change to Vanaxis

AspenBio Pharma seeks name change to Vanaxis

CASTLE ROCK - AspenBio Pharma Inc. (Nasdaq: APPY) will ask its stockholders to approve changing its name to Vanaxis Inc., the company announced. AspenBio, an in vitro diagnostic company,... Read More

By: Steve Wednesday October 17, 2012 0 comments Tags: AspenBio Pharma, Castle Rock, Steve Lundy, Vanaxis

AspenBio Pharma adds industry veteran to lead AppyScore product development

AspenBio Pharma adds industry veteran to lead AppyScore product development

CASTLE ROCK - AspenBio Pharma Inc. (Nasdaq: APPY) has added medical diagnostic and biotechnology veteran Dr. Lyndal Hesterberg to lead the company's AppyScore product development, the company... Read More

By: Steve Friday August 3, 2012 0 comments Tags: AppyScore, AspenBio Pharma, Steve Lundy

AspenBio Pharma inks worldwide license agreement for its animal health assets

AspenBio Pharma inks worldwide license agreement for its animal health assets

CASTLE ROCK - AspenBio Pharma Inc. (Nasdaq: APPY) announced it has executed an exclusive worldwide license agreement with a major international animal health company, providing license and... Read More

By: Steve Tuesday July 31, 2012 0 comments Tags: AppyScore, AspenBio Pharma, Castle Rock, Colorado, Steve Lundy